Darryl Wellinghoff
Keine laufenden Positionen mehr
Profil
Darryl Wellinghoff worked as the Chief Commercial Officer at La Jolla Pharmaceutical Co. from 2019 to 2020.
Prior to that, he was the Senior Vice President-Americas at The Medicines Co. from 2001 to 2016.
He also worked as the Executive Vice President at Mainstreet Investment Co. LLC from 2016 to 2018.
Mr. Wellinghoff completed his undergraduate degree from Florida State University.
Ehemalige bekannte Positionen von Darryl Wellinghoff
| Unternehmen | Position | Ende |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | 30.09.2020 |
Mainstreet Investment Co. LLC
 Mainstreet Investment Co. LLC Investment ManagersFinance Mainstreet Investment Co. LLC specializes in investments and health solutions. It offers real estate development and management services. The company was founded by Zeke Turner in 2002 and is headquartered in Carmel, IN. | Corporate Officer/Principal | 01.01.2018 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01.01.2016 |
Ausbildung von Darryl Wellinghoff
| Florida State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Mainstreet Investment Co. LLC
Mainstreet Investment Co. LLC Investment ManagersFinance Mainstreet Investment Co. LLC specializes in investments and health solutions. It offers real estate development and management services. The company was founded by Zeke Turner in 2002 and is headquartered in Carmel, IN. | Finance |
